• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Impact of low-density lipoprotein cholesterol on cardiovascular outcomes in people with type 2 diabetes: a meta-analysis of prospective cohort studies.2 型糖尿病患者的低密度脂蛋白胆固醇对心血管结局的影响:前瞻性队列研究的荟萃分析。
Diabetes Res Clin Pract. 2013 Oct;102(1):65-75. doi: 10.1016/j.diabres.2013.07.009. Epub 2013 Aug 9.
2
Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.在 10 年发生动脉粥样硬化性心血管疾病风险低的个体中,低密度脂蛋白胆固醇与心血管死亡率的长期关联。
Circulation. 2018 Nov 20;138(21):2315-2325. doi: 10.1161/CIRCULATIONAHA.118.034273.
3
Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.糖化血红蛋白、收缩压和 LDL 胆固醇控制对 2 型糖尿病患者心血管疾病住院风险的独立贡献:一项观察性队列研究。
J Gen Intern Med. 2013 May;28(5):691-7. doi: 10.1007/s11606-012-2320-1. Epub 2013 Jan 24.
4
Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.多囊卵巢综合征女性的长期心脏代谢疾病风险:系统评价和荟萃分析。
Hum Reprod Update. 2020 Nov 1;26(6):942-960. doi: 10.1093/humupd/dmaa029.
5
The association of low-density lipoprotein cholesterol with elevated arterial stiffness in adolescents and young adults with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth study.1 型和 2 型糖尿病青少年和年轻成人中低密度脂蛋白胆固醇与动脉僵硬度升高的相关性:青少年糖尿病研究(SEARCH)。
Pediatr Diabetes. 2020 Aug;21(5):863-870. doi: 10.1111/pedi.13021. Epub 2020 May 5.
6
Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.2型糖尿病血液透析患者中低密度脂蛋白胆固醇和炎症与心血管事件及死亡率的关联
Am J Kidney Dis. 2009 Nov;54(5):902-11. doi: 10.1053/j.ajkd.2009.06.029. Epub 2009 Sep 25.
7
Association of a reduction in low-density lipoprotein cholesterol with incident cardiovascular and cerebrovascular events among people with type 2 diabetes mellitus.在 2 型糖尿病患者中,低密度脂蛋白胆固醇降低与心血管和脑血管事件的发生有关。
Eur J Prev Cardiol. 2014 Jul;21(7):855-65. doi: 10.1177/2047487313481752. Epub 2013 Mar 4.
8
Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.高密度脂蛋白胆固醇与低密度脂蛋白胆固醇和载脂蛋白 B100 水平低的女性心血管事件的相关性:一项队列研究。
Ann Intern Med. 2011 Dec 6;155(11):742-50. doi: 10.7326/0003-4819-155-11-201112060-00006.
9
Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes.皮肤自发荧光可预测 2 型糖尿病患者的新发心血管疾病和死亡风险。
BMC Endocr Disord. 2021 Jan 12;21(1):14. doi: 10.1186/s12902-020-00676-4.
10
LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes.低密度脂蛋白胆固醇并非1型糖尿病心血管风险的良好标志物。
Diabet Med. 2016 Mar;33(3):316-23. doi: 10.1111/dme.13007. Epub 2015 Nov 11.

引用本文的文献

1
Phenotyping lipid profiles in type 2 diabetes: Risk association and outcomes from the Cardiovascular Health Study.2型糖尿病患者血脂谱的表型分析:心血管健康研究中的风险关联及结果
Am J Prev Cardiol. 2024 Aug 26;19:100725. doi: 10.1016/j.ajpc.2024.100725. eCollection 2024 Sep.
2
Trends in obesity prevalence and cardiometabolic risk factor control in US adults with diabetes, 1999-2020.美国成年人糖尿病患者肥胖患病率和心血管代谢风险因素控制的趋势,1999-2020 年。
Obesity (Silver Spring). 2023 Mar;31(3):841-851. doi: 10.1002/oby.23652. Epub 2023 Jan 25.
3
Longitudinal Adherence to Diabetes Quality Indicators and Cardiac Disease: A Nationwide Population-Based Historical Cohort Study of Patients With Pharmacologically Treated Diabetes.长期坚持糖尿病质量指标与心脏疾病:基于全国人口的药物治疗糖尿病患者的历史队列研究。
J Am Heart Assoc. 2022 Oct 4;11(19):e025603. doi: 10.1161/JAHA.122.025603. Epub 2022 Sep 21.
4
Identifying Patient Profiles for Developing Tailored Diabetes Self-Management Interventions: A Latent Class Cluster Analysis.识别用于制定个性化糖尿病自我管理干预措施的患者概况:潜在类别聚类分析
Risk Manag Healthc Policy. 2022 May 13;15:1055-1063. doi: 10.2147/RMHP.S355470. eCollection 2022.
5
Diabetes complications and extracellular vesicle therapy.糖尿病并发症与细胞外囊泡治疗。
Rev Endocr Metab Disord. 2022 Jun;23(3):357-385. doi: 10.1007/s11154-021-09680-y. Epub 2021 Oct 14.
6
Association between ANGPTL3, 4, and 8 and lipid and glucose metabolism markers in patients with diabetes.在糖尿病患者中,ANGPTL3、4 和 8 与脂质和葡萄糖代谢标志物的关系。
PLoS One. 2021 Jul 22;16(7):e0255147. doi: 10.1371/journal.pone.0255147. eCollection 2021.
7
Association between lipoprotein cholesterol and future cardiovascular disease and mortality in older adults: a Korean nationwide longitudinal study.脂蛋白胆固醇与老年人未来心血管疾病和死亡率的关系:一项韩国全国性纵向研究。
Lipids Health Dis. 2021 Jan 6;20(1):3. doi: 10.1186/s12944-020-01426-0.
8
Japanese Clinical Practice Guideline for Diabetes 2019.《2019年日本糖尿病临床实践指南》
J Diabetes Investig. 2020 Jul;11(4):1020-1076. doi: 10.1111/jdi.13306.
9
Japanese Clinical Practice Guideline for Diabetes 2019.《2019年日本糖尿病临床实践指南》
Diabetol Int. 2020 Jul 24;11(3):165-223. doi: 10.1007/s13340-020-00439-5. eCollection 2020 Jul.
10
Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: a secondary analysis of the REASON trial.在他汀类药物治疗的 2 型糖尿病患者中,阿格列汀与西格列汀的脂质代谢差异:REASON 试验的二次分析。
Cardiovasc Diabetol. 2019 Nov 16;18(1):158. doi: 10.1186/s12933-019-0965-3.

本文引用的文献

1
Standards of medical care in diabetes--2013.《糖尿病医疗护理标准——2013》
Diabetes Care. 2013 Jan;36 Suppl 1(Suppl 1):S11-66. doi: 10.2337/dc13-S011.
2
Association of glycosylated hemoglobin level with lipid ratio and individual lipids in type 2 diabetic patients.糖化血红蛋白水平与 2 型糖尿病患者血脂比值及单项血脂的相关性。
Asian Pac J Trop Med. 2012 Jun;5(6):469-71. doi: 10.1016/S1995-7645(12)60080-7.
3
LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos.LDL-胆固醇与 HDL-胆固醇在动脉粥样硬化斑块中的作用:炎症消退与血栓形成混乱。
Ann N Y Acad Sci. 2012 Apr;1254:18-32. doi: 10.1111/j.1749-6632.2012.06480.x.
4
Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study.比较各种血脂变量作为 2 型糖尿病日本男女冠心病的预测指标:日本糖尿病并发症研究的亚分析。
Diabetes Care. 2012 May;35(5):1150-7. doi: 10.2337/dc11-1412. Epub 2012 Feb 14.
5
IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.国际糖尿病联盟糖尿病地图集:2011 年和 2030 年全球糖尿病患病率估计。
Diabetes Res Clin Pract. 2011 Dec;94(3):311-21. doi: 10.1016/j.diabres.2011.10.029. Epub 2011 Nov 12.
6
The association between body mass index, lipid profile and serum estradiol levels in a sample of iraqi diabetic premenopausal women.伊拉克绝经前糖尿病女性样本中体重指数、血脂谱与血清雌二醇水平之间的关联。
Oman Med J. 2011 Jul;26(4):263-6. doi: 10.5001/omj.2011.63.
7
Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS).血清甘油三酯水平是日本 2 型糖尿病患者冠心病的一个强有力的危险因素,与 LDL 胆固醇相当:日本糖尿病并发症研究(JDCS)的亚组分析。
J Clin Endocrinol Metab. 2011 Nov;96(11):3448-56. doi: 10.1210/jc.2011-0622. Epub 2011 Aug 24.
8
Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register.不同血脂指标在 2 型糖尿病患者冠心病预测中的临床应用:来自瑞典国家糖尿病登记处的报告。
Diabetes Care. 2011 Sep;34(9):2095-100. doi: 10.2337/dc11-0209. Epub 2011 Jul 20.
9
A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk.一项关于低密度脂蛋白胆固醇、非高密度脂蛋白胆固醇和载脂蛋白B作为心血管风险标志物的荟萃分析。
Circ Cardiovasc Qual Outcomes. 2011 May;4(3):337-45. doi: 10.1161/CIRCOUTCOMES.110.959247. Epub 2011 Apr 12.
10
Update on lipids, inflammation and atherothrombosis.血脂、炎症与动脉血栓形成的最新进展。
Thromb Haemost. 2011 May;105 Suppl 1:S34-42. doi: 10.1160/THS10-11-0717. Epub 2011 Apr 11.

2 型糖尿病患者的低密度脂蛋白胆固醇对心血管结局的影响:前瞻性队列研究的荟萃分析。

Impact of low-density lipoprotein cholesterol on cardiovascular outcomes in people with type 2 diabetes: a meta-analysis of prospective cohort studies.

机构信息

Pennington Biomedical Research Center, Baton Rouge, LA, United States; School of Human Ecology, Louisiana State University AgCenter, Baton Rouge, LA, United States; Department of Experimental Statistics, Louisiana State University, Baton Rouge, LA, United States.

出版信息

Diabetes Res Clin Pract. 2013 Oct;102(1):65-75. doi: 10.1016/j.diabres.2013.07.009. Epub 2013 Aug 9.

DOI:10.1016/j.diabres.2013.07.009
PMID:23932206
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4141536/
Abstract

AIMS

To estimate the prospective association of low-density lipoprotein (LDL) cholesterol on cardiovascular disease (CVD) risk among people with type 2 diabetes.

METHODS

We used extensive literature searching strategies to locate prospective cohort studies that reported LDL cholesterol levels as a risk factor for cardiovascular events. We conducted meta-analytic procedures for two outcomes: incident CVD and CVD mortality.

RESULTS

A total of 16 studies were included in this analysis with a mean follow-up range of 4.8-11 years. The pooled relative risk associated with a 1mmol/L increase in LDL cholesterol in people with type 2 diabetes was 1.30 (95% confidence interval [CI], 1.19-1.43) for incident CVD, and 1.50 (95% CI, 1.25-1.80) for CVD mortality, respectively. Subgroup analyses showed that for incident CVD, the pooled relative risk was 1.28 (95% CI, 1.17-1.41) for 7 studies adjusted for blood pressure and/or glucose concentration (or insulin concentration, glycated hemoglobin) and 1.40 (95% CI, 1.05-1.86) for 3 studies that did not adjust for these variables.

CONCLUSIONS

Our study demonstrates that LDL cholesterol was associated with an increased risk for cardiovascular outcomes in people with type 2 diabetes, independent of other conventional risk factor.

摘要

目的

评估低密度脂蛋白(LDL)胆固醇在 2 型糖尿病患者心血管疾病(CVD)风险中的前瞻性关联。

方法

我们使用广泛的文献搜索策略来定位报告 LDL 胆固醇水平作为心血管事件风险因素的前瞻性队列研究。我们对两个结局进行了荟萃分析程序:新发 CVD 和 CVD 死亡率。

结果

共有 16 项研究纳入本分析,平均随访范围为 4.8-11 年。在 2 型糖尿病患者中,LDL 胆固醇每增加 1mmol/L,与新发 CVD 相关的 pooled 相对风险为 1.30(95%置信区间 [CI],1.19-1.43),与 CVD 死亡率相关的 pooled 相对风险为 1.50(95% CI,1.25-1.80)。亚组分析显示,对于新发 CVD,在调整血压和/或血糖浓度(或胰岛素浓度、糖化血红蛋白)的 7 项研究中,pooled 相对风险为 1.28(95% CI,1.17-1.41),而在未调整这些变量的 3 项研究中,pooled 相对风险为 1.40(95% CI,1.05-1.86)。

结论

我们的研究表明,LDL 胆固醇与 2 型糖尿病患者心血管结局风险增加相关,独立于其他传统危险因素。